NOVARTIS AG-SPONSORED ADR (NVS:NYSE)
$153.09 -0.83 (-0.5392%)
Analysed NOVARTIS AG-SPONSORED ADR (NVS:NYSE) News Sources
Orionis Biosciences Announces Strategic Collaboration with Novartis to Discover and Develop Molecular Glue Medicines
10-06-2026
yahoo.com
Novartis delpacibart braxlosiran (del-brax) Phase I/II study in facioscapulohumeral muscular dystrophy (FSHD) meets primary biomarker endpoint
11-06-2026
yahoo.com
Novartis RNA drug acquired in $12B Avidity deal notches a trial win
11-06-2026
biopharmadive.com
Novartis $12bn bet on Avidity well placed after mid-stage FSHD win
11-06-2026
clinicaltrialsarena.com
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Amid US Attacks on Iran
11-06-2026
yahoo.com
Update: US Equity Futures Rise Pre-Bell After US Says Strikes Completed Against Iran
11-06-2026
yahoo.com
Novartis Reports Positive Data for Neuromuscular Disorder Drug
11-06-2026
yahoo.com
Pharma and Biotech M&A Boom Accelerates as Companies Expand Pipelines
11-06-2026
yahoo.com
Sector Update: Healthcare Stocks Higher Late Afternoon
11-06-2026
yahoo.com
Novartis RemIND data at EAACI show Rhapsido® potential as first targeted therapy for chronic inducible urticaria (CIndU)
12-06-2026
yahoo.com
What is the current price of NOVARTIS AG-SPONSORED ADR (NVS:NYSE)?
The current price of NOVARTIS AG-SPONSORED ADR (NVS:NYSE) is $153.09.
NOVARTIS AG-SPONSORED ADR (NVS:NYSE) absolute price change since previous trading day?
The absolute price change of NOVARTIS AG-SPONSORED ADR (NVS:NYSE) since the previous trading day is $-0.83.
NOVARTIS AG-SPONSORED ADR (NVS:NYSE) percentage price change since previous trading day?
The percentage price change of NOVARTIS AG-SPONSORED ADR (NVS:NYSE) since the previous trading day is -0.5392%.
What is the most recent average sentiment score for NOVARTIS AG-SPONSORED ADR (NVS:NYSE)?
The most recent average sentiment score for NOVARTIS AG-SPONSORED ADR (NVS:NYSE) is 58 out of 100.
What is the most recent average sentiment for NOVARTIS AG-SPONSORED ADR (NVS:NYSE)?
The most recent sentiment for NOVARTIS AG-SPONSORED ADR (NVS:NYSE) is .
SEC-8K** Filing Available For NOVARTIS AG-SPONSORED ADR (NVS:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.